Physical Symptoms and Vascular Warning Signs
At a Glance
Dysbetalipoproteinemia (DBL) is often a silent disease, but it can cause unique skin deposits called palmar xanthomas and significantly increase the risk of peripheral artery disease. Because physical symptoms are rare, specialized lipid testing is essential to prevent premature heart disease.
Dysbetalipoproteinemia (DBL) is often called a “silent” condition because most people have no outward physical symptoms for many years [1][2]. While the “silent” progression of plaque in the arteries is the most significant concern, there are specific physical signs and vascular symptoms that act as important warning signals for this condition.
The Unique Skin Signs (Xanthomas)
In some cases of DBL, the buildup of fats and cholesterol becomes so high that the body begins to deposit them directly under the skin [3]. These deposits are called xanthomas. While they are not dangerous on their own, they are a visible sign that the liver is struggling to clear remnants from the blood [3][1]. The good news is that with effective treatment, these xanthomas often shrink and fade away completely [4][1].
Palmar Xanthomas (The “DBL Hallmark”)
The most famous sign of DBL is xanthoma striatum palmare, or palmar xanthomas.
- What they look like: These appear as flat, yellow-to-orange streaks or discolorations specifically in the creases of your palms and the undersides of your fingers [3][5].
- How common they are: These are considered a “hallmark” of the disease, but they only appear in about 18.8% of confirmed DBL patients [3][6].
- What they mean: If you have them, it is a very strong indicator of DBL, but if you don’t have them, it does not mean you are in the clear [6].
Tuberoeruptive Xanthomas
These deposits occur where the skin is frequently under pressure or stretching.
- What they look like: They appear as firm, yellowish-pink nodules or bumps [3]. They often start small (like a “crop” of bumps) and can grow into larger, cauliflower-like clusters [5].
- Where to look: They are most commonly found on the elbows, knees, and buttocks [3][5].
Vascular Warning Signs
Because DBL causes a specific type of “sticky” cholesterol (remnants) to build up, it can damage the arteries more aggressively than standard high cholesterol [7][8]. This often shows up in two main areas: the heart and the legs.
Peripheral Artery Disease (PAD)
DBL is uniquely associated with a massive risk of Peripheral Artery Disease (PAD)—blockages in the arteries that supply blood to your legs [9].
- The Warning Sign: The most common symptom is claudication. This is a specific type of leg pain, cramping, or “heaviness” that occurs when you are walking or exercising but disappears within minutes of resting [9]. If you experience this symptom, you should inform your doctor immediately to get screened for PAD.
Premature Cardiovascular Disease
“Premature” means heart disease that occurs earlier than expected—typically before age 55 in men and 65 in women [10].
- Accelerated Plaque: Because remnants enter the arterial wall more easily than standard LDL, they can promote inflammation and plaque buildup even if your “bad” LDL cholesterol numbers look relatively normal on a standard test [7][8].
- Symptoms: This can manifest as chest pain during exertion (angina), shortness of breath, or in some cases, a heart attack as the first sign of the disease [1][2].
Why “No Symptoms” is Common
It is critical to understand that the majority of people with DBL have no xanthomas and no leg pain until the disease is quite advanced [6][2]. Relying on physical signs alone can lead to a delay in diagnosis. This is why doctors focus on advanced lipid testing to find the “hidden” remnants before they cause permanent damage to the vascular system [11][12].
Common questions in this guide
What are palmar xanthomas in DBL?
Can I have Dysbetalipoproteinemia without any skin symptoms?
Why do my legs cramp or ache when I walk?
How can I tell if my leg pain is from blocked arteries?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since I don't have xanthomas, what specific lipid ratios (like non-HDL to ApoB) led to my diagnosis?
- 2.Given the high risk of peripheral artery disease (PAD) with DBL, should I have an Ankle-Brachial Index (ABI) test to check the blood flow in my legs?
- 3.How can we tell if the aching in my legs is from 'claudication' versus a side effect of medication?
- 4.Are there any other physical signs on my skin or eyes that you are monitoring during my exams?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder.
Koopal C, Marais AD, Visseren FL
Current opinion in endocrinology, diabetes, and obesity 2017; (24(2)):133-139 doi:10.1097/MED.0000000000000316.
PMID: 28098593 - 2
Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε2ε1 Genotype.
Limonova AS, Ershova AI, Meshkov AN, et al.
Frontiers in cardiovascular medicine 2020; (7()):585779 doi:10.3389/fcvm.2020.585779.
PMID: 33537346 - 3
Palmar Striated Xanthomas in Clinical Practice.
Roy N, Gaudet D, Brisson D
Journal of the Endocrine Society 2022; (6(8)):bvac103 doi:10.1210/jendso/bvac103.
PMID: 35860753 - 4
Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts.
Heidemann BE, Wolters FJ, Kavousi M, et al.
Atherosclerosis 2021; (325()):57-62 doi:10.1016/j.atherosclerosis.2021.04.001.
PMID: 33892328 - 5
Severe Combined Dyslipidemia With a Complex Genetic Basis.
Le R, Abbas M, McIntyre AD, Hegele RA
Journal of investigative medicine high impact case reports 2019; (7()):2324709619877050 doi:10.1177/2324709619877050.
PMID: 31538826 - 6
The clinical and laboratory investigation of dysbetalipoproteinemia.
Boot CS, Luvai A, Neely RDG
Critical reviews in clinical laboratory sciences 2020; (57(7)):458-469 doi:10.1080/10408363.2020.1745142.
PMID: 32255405 - 7
Postprandial Hyperlipidemia and Remnant Lipoproteins.
Masuda D, Yamashita S
Journal of atherosclerosis and thrombosis 2017; (24(2)):95-109 doi:10.5551/jat.RV16003.
PMID: 27829582 - 8
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.
Sniderman AD, Thanassoulis G, Glavinovic T, et al.
JAMA cardiology 2019; (4(12)):1287-1295 doi:10.1001/jamacardio.2019.3780.
PMID: 31642874 - 9
Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease.
Paquette M, Bernard S, Baass A
The Journal of clinical endocrinology and metabolism 2022; (108(1)):184-190 doi:10.1210/clinem/dgac503.
PMID: 36056815 - 10
Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study.
Blokhina AV, Ershova AI, Kiseleva AV, et al.
PloS one 2024; (19(12)):e0315693 doi:10.1371/journal.pone.0315693.
PMID: 39705280 - 11
Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia.
Sniderman AD
Clinical chemistry 2019; (65(2)):225-227 doi:10.1373/clinchem.2018.298026.
PMID: 30538123 - 12
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial Dysbetalipoproteinemia.
Heidemann BE, Koopal C, Roeters van Lennep JE, et al.
Clinica chimica acta; international journal of clinical chemistry 2023; (539()):114-121 doi:10.1016/j.cca.2022.11.035.
PMID: 36493875
This page explains the physical symptoms and vascular warning signs of Dysbetalipoproteinemia (DBL) for educational purposes only. It does not replace professional medical advice, and you should always consult your doctor to evaluate any new symptoms.
Get notified when new evidence is published on Dysbetalipoproteinemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.